Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer
Main Authors: | Macbeth, F, Griffiths, G, Noble, S, Burns, S, Maughan, T |
---|---|
格式: | Journal article |
出版: |
2009
|
相似書籍
-
FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer
由: Griffiths, G, et al.
出版: (2009) -
FRAGMATIC: A randomised phase III clinical trial investigating the effect of <b>fragm</b>in<sup>® </sup><b>a</b>dded to standard <b>t</b>herapy <b>i</b>n patients with lung <b>c</b>ancer
由: Macbeth Fergus R, et al.
出版: (2009-10-01) -
Gelsolin-Like Domain 3 Plays Vital Roles in Regulating the Activities of the Lily Villin/Gelsolin/Fragmin Superfamily.
由: Dong Qian, et al.
出版: (2015-01-01) -
Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised controlled trial
由: Anders Kjellberg, et al.
出版: (2023-01-01) -
Randomised clinical trial: 3-year interim analysis results of the VISION trial to evaluate the long-term safety of vonoprazan as maintenance treatment in patients with erosive oesophagitis
由: Ken Haruma, et al.
出版: (2023-05-01)